SP-303 small-particle aerosol treatment of influenza A virus infection in mice and respiratory syncytial virus infection in cotton rats

Antiviral Res. 1993 May;21(1):37-45. doi: 10.1016/0166-3542(93)90065-q.

Abstract

A natural plant product, SP-303, was administered by small-particle aerosol to influenza A/HK virus-infected mice and RSV-infected cotton rats. Aqueous SP-303 at 2 mg/ml in the Collison nebulizer reservoir generated an aerosol with an output of 26 micrograms/l and a particle size distribution of 1.4 microns +/- 4.6 (MMAD +/- GSD). SP-303 at a dosage of 0.5-9.4 mg/kg per day administered for 3-4 days significantly increased both the rate and duration of survival of mice lethally infected with influenza A/HK virus. SP-303 was toxic to mice at 16 mg/kg per day as indicated by weight loss and a decrease in the duration of survival compared to control animals. From these data, a maximum therapeutic index (T.I.) of 12 was calculated. SP-303 given 3-4 days at dosages of 1.3-9.8 mg/kg per day was effective in reducing the pulmonary titer of RSV in infected cotton rats. However, at the 18.7 mg/kg per day dose a significant weight loss compared to control animals was observed; a T.I. of < or = 14 was estimated. These experiments demonstrate that aerosol administration of SP-303 was effective in the treatment of influenza A-infected mice and of RSV-infected cotton rats.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Inhalation
  • Aerosols
  • Animals
  • Antiviral Agents / pharmacokinetics
  • Antiviral Agents / pharmacology*
  • Biopolymers
  • Catechin / analogs & derivatives*
  • Catechin / pharmacokinetics
  • Catechin / pharmacology
  • Dose-Response Relationship, Drug
  • Humans
  • Influenza A virus*
  • Influenza, Human / drug therapy*
  • Influenza, Human / microbiology
  • Mice
  • Mice, Inbred ICR
  • Plant Extracts / pharmacology
  • Rats
  • Respiratory Syncytial Viruses*
  • Respirovirus Infections / drug therapy*
  • Respirovirus Infections / microbiology
  • Therapeutic Equivalency

Substances

  • Aerosols
  • Antiviral Agents
  • Biopolymers
  • Plant Extracts
  • Catechin
  • crofelemer